InMed Pharmaceuticals Inc

NASDAQ:INM  
1.68
-0.01 (-0.59%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)13.53M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.25 Million
Adjusted EPS-$0.23
See more estimates
10-Day MA$1.67
50-Day MA$1.63
200-Day MA$2.76
See more pivots

InMed Pharmaceuticals Inc Stock, NASDAQ:INM

815 West Hastings Street, Suite 310, Vancouver, British Columbia V6C 1B4
Canada
Phone: +1.604.669.7207
Number of Employees:

Description

InMed Pharmaceuticals, Inc. engages in the provision of biopharmaceutical research and development of novel. It also involves in cannabinoid-based therapies and a biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.